AKT1 and ovarian carcinoma: The overexpression of miR-21, for example, has been shown to contribute to cisplatin resistance in ovarian cancer cells by targeting the pro-apoptotic gene PTEN, leading to the activation of the PI3K/AKT pathway and increased cell survival [46].